JUN 21, 2018 5:25 AM PDT

The Silver Tsunami: An Aging Immune System and Cancer

WRITTEN BY: Kara Marker

Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look to immune cells for an answer. From Monash University, researchers show how age-related inflammation, or “inflamm-aging,” could be to blame for increased incidence of cancer as people get older.

Life expectancy in the United States and worldwide is significantly higher than it was half a century ago. Experts estimate that by 2050, more than 20 percent of the population will be older than 65. This means that over 20 percent of the population will be at an increased risk of cancer, all because weak immune cells grow in number and strong immune cells fade away.

Specifically, Monash University scientists describe “virtual memory T cells” and “true naïve T cells.” The former are prone to losing their ability to become activated, leaving them essentially useless in fighting pathogens and preventing cancer. Researchers found that these cells make up just five percent of T cells in young animal models and younger humans, but they increase significantly with old age.

True naïve T cells, unlike virtual memory T cells, keep their ability to become activated and participate in an immune response, but this population of cells decreases significantly as people get older. Researchers found that these cells go from 90 percent of the T cell population to just 30 percent. So as people age, they lose the cells that they need to fight off infection and prevent cancer, and they gain the cells too weak to put up a fight.

Accumulation of the virtual memory T cell population paired with the progressive loss of true naïve T cells is the perfect storm to explain the increased incidence of cancer associated with older age. Additionally, these changes prevent older people from mounting an effective immune response to vaccines, and reduce the chances of success with cancer immunotherapy.

"In cancer immunotherapy, a patient's own T cells are stimulated to kill cancer cells and it has been hugely successful for certain forms of cancer,” explained Nicole La Gruta. “Unfortunately, older patients or people over 65 years of age respond less well than younger ones.”

A potential solution is to selectively target each population of T cells to reduce the incidence of cancer in older people. For example, reduce the amount of virtual memory T cells and/or increase the amount of true naïve T cells. This approach could improve treatment and prevention of cancer.

“We may be able to tailor cancer immunotherapy specifically for the needs of an older patient's immune system- this is where medicine must head to meet the needs of our ageing society,” La Gruta explained.

Norman E. Sharpless, MD, wrote about cancer and aging in a January Cancer Currents Blog: “It’s clear that we need to better understand how the biological underpinnings of aging affect the onset and trajectory of cancer to address this looming public health challenge.”

The present study was published in the journal Cell Reports.

Sources: National Cancer Institute, Monash University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
JAN 04, 2022
Immunology
Scientists Win a Game of Bacterial Hide-And-Seek
JAN 04, 2022
Scientists Win a Game of Bacterial Hide-And-Seek
When infection strikes, antibiotics are the go-to solution to help patients regain control from the invading bacter ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 13, 2022
Immunology
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
JAN 13, 2022
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
A recent study has demonstrated that COVID-19 convalescent plasma treatment (or blood from individuals who have recovere ...
JAN 17, 2022
Cancer
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
JAN 17, 2022
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
Immune checkpoint inhibitors (ICIs) have become a promising new treatment for advanced cancers, including melanoma. Immu ...
Loading Comments...